Mercy BioAnalytics Raises $59 Million Series B to Advance Cancer Detection Platform
The funding will support commercialization of the company's extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.
The funding will support commercialization of the company's extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.
At ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.
CAP has updated 23 cancer protocols to align with the latest standards from AJCC and WHO, enhancing diagnostic precision and patient care.
New predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.
Read MoreDespite limited progress in prognosis, recent advancements in molecular diagnostics is transforming diagnosis of cancer of unknown primary.
Read MoreArtificial intelligence (AI) with mathematical modeling, while useful, isn’t the only method that should be used in cancer prediction.
Read MoreMULGONET, a novel multi-omics framework, improves tumor recurrence prediction by integrating gene ontology-guided architecture.
Read MoreA study highlights the role of exRNA in head and neck cancers (HNCs), emphasizing their potential as non-invasive biomarkers for diagnosis.
Read MoreThe ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read MoreLeica Biosystems and Indica Labs will develop a next-gen digital pathology platform and accelerate AI-enabled CDx for cancer care.
Read MoreA new study introduced an AI-powered diagnostic model with 94.49% accuracy to improve skin cancer detection and patient outcomes.
Read MoreGenomenon, Inc. has announced the development of the G3 knowledgebase, an advanced genomic AI platform that consolidates genomic data.
Read MoreFunction Health will offer GRAIL’s Galleri multi-cancer early detection test, empowering proactive cancer care through a simple blood draw.
Read MoreResearchers identified 27 protein biomarkers in blood serum that can predict cardiomyopathy risk in pediatric cancer survivors.
Read MoreThe Center for Innovation and Translation of POC Technologies for Equitable Cancer Care showcased POC innovations for cancer detection.
Read MoreSakura Finetek Europe and MEDIPATH partnered to enhance cancer diagnostics by deploying automated embedding systems in key pathology centers.
Read MoreResearchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read MoreResearchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.
Read More